<code id='978D3E9AB8'></code><style id='978D3E9AB8'></style>
    • <acronym id='978D3E9AB8'></acronym>
      <center id='978D3E9AB8'><center id='978D3E9AB8'><tfoot id='978D3E9AB8'></tfoot></center><abbr id='978D3E9AB8'><dir id='978D3E9AB8'><tfoot id='978D3E9AB8'></tfoot><noframes id='978D3E9AB8'>

    • <optgroup id='978D3E9AB8'><strike id='978D3E9AB8'><sup id='978D3E9AB8'></sup></strike><code id='978D3E9AB8'></code></optgroup>
        1. <b id='978D3E9AB8'><label id='978D3E9AB8'><select id='978D3E9AB8'><dt id='978D3E9AB8'><span id='978D3E9AB8'></span></dt></select></label></b><u id='978D3E9AB8'></u>
          <i id='978D3E9AB8'><strike id='978D3E9AB8'><tt id='978D3E9AB8'><pre id='978D3E9AB8'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:fashion    Page View:9893
          Influenza A virions
          F. A. Murphy/CDC

          Vir Biotechnology said Thursday that a long-acting antibody drug designed to protect healthy individuals from influenza A failed to do so in a nearly 3,000-person clinical trial.

          Volunteers who received the highest dose of the drug, known as VIR-2482, were only 16% less likely than the placebo group to develop symptomatic influenza A infections, as defined by trial criteria, over a seven-month period. The difference was not statistically significant.

          advertisement

          The results are a setback in broader efforts to develop better protective measures against both seasonal and potential pandemic influenza strains. In the short term, Vir and outside experts hoped VIR-2482 could provide additional annual protection for at-risk groups like older adults, as flu vaccines are often only modestly effective.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more
          How to fix the rural physician shortage in the U.S.
          How to fix the rural physician shortage in the U.S.

          AdobeAsthedeansofthetwopublicmedicalschoolsinNevada,wearewatchingwithprideasourrecentgraduatesprepar

          read more
          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more

          Tennessee law changes starting July 1 will restrict trans health care and fund more school safety

          FILE-TravelersmaketheirwaythroughtheNashvilleInternationalAirport,May25,2023,inNashville,Tenn.Months